Diffusion Pharmaceuticals (DFFN) Stock: Soaring On Patent News


Diffusion Pharmaceuticals Inc (NASDAQ: DFFN)

Diffusion Pharmaceuticals was off to a relatively normal day in the market today. However, that all changed minutes ago, when the company was awarded a new key patent. As a result, the stock spiked dramatically, prompting our partners at Trade Ideas to send the alert and the CNA Finance team to start digging. At the moment (11:30), DFFN is trading at $4.52 per share after a gain of $1.78 per share (65.03%) thus far today.

DFFN Awarded New Patnet

As mentioned above, Diffusion Pharmaceuticals exploded in value minutes ago as a new patent was awarded to the company. The patent relates to trans-carotenoid salt compounds and involves the method of making them, methods for solubilizing them, and uses of the carotenoid salt compounds themselves. In particular, the compounds are useful in improving diffusivity of oxygen between red blood cells and body tissues in mammals, including humans.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on DFFN. In particular, we’re interested in following the company through the process of growth, and we will be digging further into this patent for more details. We’ll continue to follow the story closely and bring you the news as it breaks!

What Do You Think?

Where do you think DFFN is headed moving forward? Join the discussion in the comments below!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required

[Image Courtesy of Pixabay]


Please enter your comment!
Please enter your name here